| Financial Year |
March 31 2023 |
| Monetary Funds |
25,637,530.70 |
| Held-for-trading Financial Assets |
153,061.15 |
| Notes Receivable |
-- |
| Accounts Receivable |
77,066,984.91 |
| Advances to Suppliers |
4,532,608.31 |
| Other Receivables |
9,962,847.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
410,622,090.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,505,357.57 |
| Total Current Assets |
544,569,065.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
321,871.69 |
| Investment Properties |
35,553,265.57 |
| Fixed Assetes |
48,834,618.49 |
| Under-construction Projects |
2,327,010.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,473,491.28 |
| R&D expenses |
15,580,000.00 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
5,978,289.39 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
168,308,257.58 |
| Total Assets |
712,877,322.62 |
| Short-Term Loans |
16,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
55,487,265.94 |
| Accounts Received In Advance |
6,869,270.83 |
| Employee Compensation Payable |
530,623.95 |
| Taxes Payable |
6,487,634.08 |
| Interest Payable |
-- |
| Dividend Payable |
668,239.82 |
| Other payables |
8,030,905.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,383,992.39 |
| Other Current Liabilities |
2,980,530.16 |
| Sub-Total of Current Liabilities |
112,061,767.39 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
28,442,409.45 |
| Total Liabilities |
140,504,176.84 |
| Paid-In Capital(Or Share Stock) |
1,029,556,222.00 |
| Capital Surplus |
35,572,769.72 |
| Surplus Reserve |
37,856,747.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-565,581,208.49 |
| Minority Stockholder's Interest |
34,091,403.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
538,281,742.59 |
| Owner's Equity（Stockholder's Equity） |
572,373,145.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
712,877,322.62 |
